Tatjana Welzel
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study.
Journal: Pediatric rheumatology online journal
Published: July 14, 2025
Juvenile idiopathic arthritis-Diagnosis and management
Journal: Zeitschrift fur Rheumatologie
Published: January 15, 2025
Influence of Disease Type and Activity on Adalimumab Exposure in Children with Inflammatory Rheumatic Diseases.
Journal: Journal of clinical pharmacology
Published: December 20, 2024
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner.
Journal: Cell chemical biology
Published: November 12, 2024
Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland.
Journal: BMJ open
Published: April 26, 2024
Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments.
Journal: Journal of clinical medicine
Published: March 16, 2024
Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markers.
Journal: Rheumatology (Oxford, England)
Published: March 04, 2024
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.
Journal: The Pediatric infectious disease journal
Published: January 19, 2024
Patient Experiences and Challenges in the Management of Autoinflammatory Diseases-Data from the International FMF & AID Global Association Survey.
Journal: Journal of clinical medicine
Published: January 17, 2024
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.
Journal: Pediatric rheumatology online journal
Published: August 30, 2023
Last Updated: 09/26/2026